Good physical performance is associated with better cognition in people with relapsing-remitting MS, according to a recent study by the University of Eastern Finland. Good functional capacity was also ...

Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis ...

'Drag Race's Lexi Love on relapsing, getting sober and finding her happily ever after "I had to prove myself and my love for him or dedication to sobriety." ...

A funny take on the struggle to resist temptation and then falling back into it. A short but relatable sketch.

It has already shown therapeutic activity in phase 2 clinical trials in patients suffering from relapsing-remitting multiple sclerosis and progressive multiple sclerosis.

But in 2020 Jessica, a project manager and DJ from Macclesfield, Cheshire, was diagnosed with relapsing-remitting multiple sclerosis (MS).

Kesimpta was approved in August 2020 as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing ...

These results are awaiting confirmation in the three ongoing Phase III clinical trials evaluating FTY720 for relapsing–remitting multiple sclerosis.